pilocarpine has been researched along with Glaucoma, Neovascular in 1 studies
Pilocarpine: A slowly hydrolyzed muscarinic agonist with no nicotinic effects. Pilocarpine is used as a miotic and in the treatment of glaucoma.
(+)-pilocarpine : The (+)-enantiomer of pilocarpine.
Glaucoma, Neovascular: A form of secondary glaucoma which develops as a consequence of another ocular disease and is attributed to the forming of new vessels in the angle of the anterior chamber.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bergeå, B | 1 |
| Svedbergh, B | 1 |
1 trial available for pilocarpine and Glaucoma, Neovascular
| Article | Year |
|---|---|
Primary argon laser trabeculoplasty vs. pilocarpine. Short-term effects.
Topics: Follow-Up Studies; Glaucoma, Neovascular; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Laser | 1992 |